General Information
|
|
Product
|
EFEMP1 Peptide
|
Description
|
Antigenic Blocking Peptide EGF-containing fibulin-like extracellular matrix protein 1
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
Peptide Description
|
Synthetic cyclic peptide corresponding to N terminal amino acids 25-42 of Human EFEMP1, peptide was covalently modified.
Sequence:
TYTQCTDGYEWDPVRQQC
|
Accession #
|
NCBI: XP_005264262.1
|
Physical Properties
|
|
Quantity
|
250 µg
|
Volume
|
100 µl
|
Form
|
Antigenic Blocking Peptide
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
Protein
|
Uniprot #
|
UPI000387D485
|
Overview
|
Binds EGFR, the EGF receptor, inducing EGFR autophosphorylation and the activation of downstream signaling pathways. May play a role in cell adhesion and migration. May function as a negative regulator of chondrocyte differentiation. In the olfactory epithelium, it may regulate glial cell migration, differentiation and the ability of glial cells to support neuronal neurite outgrowth.
|
Molecular Function
|
Calcium
|
Subcellular Location
|
Secreted; Extracellular space
|
Expression
|
In the eye, associated with photoreceptor outer and inner segment regions, the nerve fiber layer, outer nuclear layer and inner and outer plexiform layers of the retina.
|
Structure
|
Interacts with ECM1. Interacts with TIMP3.
|
Alternative Nomenclature
|
DHRD antibody
Doyne honeycomb retinal degeneration antibody
DRAD antibody
EFEMP 1 antibody
Epidermal growth factor containing fibulin like extracellular matrix protein 1 antibody
FBLN3 antibody
Fibrillin like antibody
FIBULIN 3 antibody
FLJ35535 antibody
Heat shock 70 KD protein 1 antibody
MGC111353 antibody
MLVT antibody
T16 protein antibody
|
|
|